Endoscopic surveillance: time for a paradigm shift in hereditary diffuse-type gastric cancer management?

Lancet Oncol. 2023 Apr;24(4):311-312. doi: 10.1016/S1470-2045(23)00094-3.

Authors

Rachel Sophia van der Post¹, Tanya Maria Bisseling², Jolanda Marianne van Dieren³

Affiliations

¹ Department of Pathology, Radboud University Medical Centre, Nijmegen 6525 GA, Netherlands. Electronic address: chella.vanderpost@radboudumc.nl.
² Department of Gastroenterology, Radboud University Medical Centre, Nijmegen 6525 GA, Netherlands.
³ Department of Gastrointestinal Oncology, The Netherlands Cancer Institute, Amsterdam, Netherlands.

PMID: 36990606
DOI: 10.1016/S1470-2045(23)00094-3

No abstract available

Publication types

Comment

MeSH terms

Adenocarcinoma* / surgery
Endoscopy
Gastrectomy
Genetic Predisposition to Disease
Germ-Line Mutation
Humans
Stomach Neoplasms* / surgery
Stomach Neoplasms* / therapy